IMRX Immuneering Corporation logo

IMRX Immuneering Corporation

Healthcare
$5.39+3.26%ClosedMarket Cap: $195.7M

As of 2026-05-25

Insider Statistics (Q1 2026)

Acquisitions

14

Dispositions

0

Buy/Sell Ratio

0.00

Net Shares

+1,835,595

Shares Acquired

1,835,595

Shares Disposed

0

Total Bought ($)

$5.00

Total Sold ($)

$0.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Tue Mar 17Neufeld Leah Rofficer: CHIEF PEOPLE OFFICERSell3,628$4.2929,598
Thu Feb 05Zeskind Benjamin J.director, officer: PRESIDENT AND CEOSell688,000$4.91688,000
Thu Feb 05Neufeld Leah Rofficer: CHIEF PEOPLE OFFICERSell140,000$4.91140,000
Thu Feb 05Morales Malloryofficer: SVP Finance, CAOSell140,000$4.91140,000
Thu Feb 05Matushansky Igorofficer: Chief Medical OfficerSell140,000$4.91140,000
Thu Feb 05Hall Brett Matthewofficer: CHIEF SCIENTIFIC OFFICERSell344,000$4.91344,000
Thu Feb 05Brakewood Harold Eugeneofficer: Chief Business OfficerSell140,000$4.91140,000
Thu Feb 05Bookman Michaelofficer: CHIEF LEGAL OFFICER, SECRETARYSell176,000$4.91176,000
Wed Jan 21Brakewood Harold Eugeneofficer: Chief Business OfficerBuy5,250$4.7611,050
Tue Jan 20Schall Thomas J.directorBuy21,645$4.6774,530